Fremanezumab
DrugBank ID: DB14041
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| migraine with brainstem aura | 0.9994 | DL |
| migraine disorder | 0.9994 | KG+DL |
| migraine with or without aura, susceptibility to | 0.9934 | DL |
| atrophoderma vermiculata | 0.9904 | DL |
| ulerythema ophryogenesis | 0.9864 | DL |
| heparin cofactor 2 deficiency | 0.9688 | DL |
| antithrombin deficiency type 2 | 0.9637 | DL |
| factor 5 excess with spontaneous thrombosis | 0.9625 | DL |
| thrombophilia | 0.9431 | DL |
| amenorrhea (disease) | 0.9274 | DL |
| sciatic neuropathy | 0.9032 | DL |
| hemorrhagic disease of newborn | 0.8075 | DL |
| severe nonproliferative diabetic retinopathy | 0.6597 | DL |
| hyperemesis gravidarum (disease) | 0.6424 | DL |
| hyperparathyroidism, primary, caused by water clear cell hyperplasia | 0.6019 | DL |
| omphalocele (disease) | 0.5979 | DL |
| sudden arrhythmia death syndrome | 0.5933 | DL |
| cauda equina syndrome | 0.5898 | DL |
| prekallikrein deficiency | 0.5892 | DL |
| Coronavinae infectious disease | 0.5876 | DL |
| tibial adamantinoma | 0.5843 | DL |
| non-specific granulomatous orchitis | 0.5820 | DL |
| cholangiocarcinoma, susceptibility to | 0.5817 | DL |
| Taylor syndrome | 0.5803 | DL |
| adhesions of uterus | 0.5803 | DL |
| chronic subinvolution of uterus | 0.5803 | DL |
| female infertility of uterine origin | 0.5803 | DL |
| uterine inversion | 0.5803 | DL |
| amelia of upper limb | 0.5780 | DL |
| male infertility due to sperm disorder | 0.5753 | DL |
| polydactyly of an index finger, unilateral | 0.5744 | DL |
| Marin-Amat syndrome | 0.5740 | DL |
| inverse Marcus-Gunn phenomenon | 0.5740 | DL |
| split foot, bilateral | 0.5677 | DL |
| split foot, unilateral | 0.5677 | DL |
| Polymerase proofreading-related adenomatous polyposis | 0.5670 | DL |
| alacrima, congenital | 0.5663 | DL |
| mitral valve prolapse, myxomatous | 0.5655 | DL |
| writing disorder | 0.5650 | DL |
| PDA1 | 0.5644 | DL |
| aphasia | 0.5638 | DL |
| mixed receptive-expressive language disorder | 0.5638 | DL |
| T-cell immunodeficiency | 0.5627 | DL |
| congenital cystic eye multiple ocular and intracranial anomalies | 0.5618 | DL |
| ossifying fibroma (disease) | 0.5605 | DL |
| terminal transverse defects of arm | 0.5596 | DL |
| hypercarotenemia and vitamin A deficiency, autosomal recessive | 0.5592 | DL |
| trichostrongylosis | 0.5591 | DL |
| odontochondrodysplasia 2 with hearing loss and diabetes | 0.5580 | DL |
| Celosomia | 0.5574 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.